Target intelligence / Profile preview

Interferon alpha-21 (IFNA21)

Target
IFNA21
Molecular classification
Cytokine, Type I interferon, Immune signaling protein
01

Overview

Interferon alpha-21 (IFNA21) is a type I interferon, a cytokine protein encoded by the IFNA21 gene in humans. Produced mainly by macrophages, IFNA21 exerts strong antiviral effects, interfering with viral replication by stimulating the production of antiviral enzymes and promoting an immune response. It acts on type I interferon receptors and is involved in activating natural killer cells, stimulating B cell proliferation, and the differentiation of various immune cells. IFNA21 is implicated in several disease processes, particularly viral infections and certain inflammatory syndromes. Therapeutically, interferon alphas are used for chronic viral infections and some malignancies but have notable side effects including flu-like symptoms, hematologic toxicities, neuropsychiatric symptoms, and possible exacerbation of autoimmune conditions.

Other names
Interferon alpha-21IFNA21IFN-alpha-21Interferon alpha-FIFN-alphaILeIF FleIF-Fleukocyte interferon proteinIFN21
02

Mechanism of action

Activation of interferon alpha receptors (type I interferon receptor); Induction of antiviral gene expression; Immune system modulation via JAK-STAT signaling pathway

03

Biological functions

Antiviral activityImmune response modulationNatural killer cell activationB cell differentiation and proliferationInduction of enzyme production (protein kinase, oligoadenylate synthetase)
04

Disease associations

InfectionInflammationMultisystem Inflammatory Syndrome in ChildrenMastocytosis, cutaneousPotential roles in coronary artery disease risk
05

Safety considerations

Flu-like symptomsCytopenias (e.g., neutropenia, anemia, thrombocytopenia)Depression and neuropsychiatric effectsAutoimmune exacerbationHepatic dysfunction
06

Interacting drugs

Interferon alfa therapeutic formulations (e.g., interferon alfa-2a, interferon alfa-2b)

1 more in the full profile.

07

Biomarkers

Null (no specific, widely-used IFNA21-specific biomarker for patient selection or efficacy identified)

Beyond the preview

Go deeper on Interferon alpha-21 (IFNA21).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Interferon alpha-21 (IFNA21).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call